Next Article in Journal
Molecular Cytogenetics in Trough Shells (Mactridae, Bivalvia): Divergent GC-Rich Heterochromatin Content
Next Article in Special Issue
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Previous Article in Journal
Imbalance between Glutamate and GABA in Fmr1 Knockout Astrocytes Influences Neuronal Development
Previous Article in Special Issue
Telomerase: The Devil Inside

Telomere Transcripts Target Telomerase in Human Cancer Cells

Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, Vienna 1090, Austria
Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna 1210, Austria
Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA
Author to whom correspondence should be addressed.
Co-last author
Academic Editor: Gabriele Saretzki
Received: 9 June 2016 / Revised: 24 July 2016 / Accepted: 29 July 2016 / Published: 16 August 2016
(This article belongs to the Special Issue Telomerase Activity in Human Cells)
Long non-coding transcripts from telomeres, called telomeric repeat-containing RNA (TERRA), were identified as blocking telomerase activity (TA), a telomere maintenance mechanism (TMM), in tumors. We expressed recombinant TERRA transcripts in tumor cell lines with TA and with alternative lengthening of telomeres (ALT) to study effects on TMM and cell growth. Adeno- and lentivirus constructs (AV and LV) were established for transient and stable expression of approximately 130 units of telomere hexanucleotide repeats under control of cytomegalovirus (CMV) and human RNase P RNA H1 (hH1) promoters with and without polyadenylation, respectively. Six human tumor cell lines either using telomerase or ALT were infected and analyzed for TA levels. Pre-infection cells using telomerase had 1%–3% of the TERRA expression levels of ALT cells. AV and LV expression of recombinant TERRA in telomerase positive cells showed a 1.3–2.6 fold increase in TERRA levels, and a decrease in TA of 25%–58%. Dominant-negative or small hairpin RNA (shRNA) viral expression against human telomerase reverse transcriptase (hTERT) results in senescence, not induced by TERRA expression. Population doubling time, cell viability and TL (telomere length) were not impacted by ectopic TERRA expression. Clonal growth was reduced by TERRA expression in TA but not ALT cell lines. ALT cells were not affected by treatments applied. Established cell models and tools may be used to better understand the role of TERRA in the cell, especially for targeting telomerase. View Full-Text
Keywords: telomerase; enzyme inhibition; telomere; long non-coding transcript; viral expression systems; tumor cell lines; human; canine telomerase; enzyme inhibition; telomere; long non-coding transcript; viral expression systems; tumor cell lines; human; canine
Show Figures

Figure 1

MDPI and ACS Style

Kreilmeier, T.; Mejri, D.; Hauck, M.; Kleiter, M.; Holzmann, K. Telomere Transcripts Target Telomerase in Human Cancer Cells. Genes 2016, 7, 46.

AMA Style

Kreilmeier T, Mejri D, Hauck M, Kleiter M, Holzmann K. Telomere Transcripts Target Telomerase in Human Cancer Cells. Genes. 2016; 7(8):46.

Chicago/Turabian Style

Kreilmeier, Theresa, Doris Mejri, Marlene Hauck, Miriam Kleiter, and Klaus Holzmann. 2016. "Telomere Transcripts Target Telomerase in Human Cancer Cells" Genes 7, no. 8: 46.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop